A Registry Study of Biomarkers in Heart Valve Disease

RecruitingOBSERVATIONAL
Enrollment

200,000

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

January 1, 2030

Study Completion Date

January 1, 2030

Conditions
Cardiovascular Diseases
Trial Locations (1)

100029

RECRUITING

Beijing Anzhen Hospital, Beijing

All Listed Sponsors
lead

Beijing Institute of Heart, Lung and Blood Vessel Diseases

OTHER